Diabetes mellitus type 2 diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Trushatank (talk | contribs) |
Trushatank (talk | contribs) |
||
Line 9: | Line 9: | ||
==Diagnostic recommendation== | ==Diagnostic recommendation== | ||
According to the ADA criteria, fasting plasma glucose, 2-h plasma glucose during 75-g oral glucose tolerance test, and A1C are equally appropriate in diagnosing diabetes mellitus type 2.<ref>{{cite journal|title=2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2018|journal=Diabetes Care|volume=41|issue=Supplement 1|year=2017|pages=S13–S27|issn=0149-5992|doi=10.2337/dc18-S002}}</ref> | According to the ADA criteria, fasting plasma glucose, 2-h plasma glucose during 75-g oral glucose tolerance test, and A1C are equally appropriate in diagnosing diabetes mellitus type 2.<ref>{{cite journal|title=2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2018|journal=Diabetes Care|volume=41|issue=Supplement 1|year=2017|pages=S13–S27|issn=0149-5992|doi=10.2337/dc18-S002}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
!style="background:#4479BA; color: #FFFFFF;" align="center" + |'''ADA Recommendation For Diagnosis of Diabetes''' | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''ADA Recommendation For Diagnosis of Diabetes Mellitus Type 2''' | ||
|- | |- | ||
| | | | ||
Line 33: | Line 32: | ||
* Testing for type 2 diabetes should be considered in children and adolescents who are overweight or obese (BMI >85th percentile for age and sex, weight for height >85th percentile, or weight >120% of ideal for height) and who have additional risk factors for diabetes | * Testing for type 2 diabetes should be considered in children and adolescents who are overweight or obese (BMI >85th percentile for age and sex, weight for height >85th percentile, or weight >120% of ideal for height) and who have additional risk factors for diabetes | ||
|- | |- | ||
|style="background:#DCDCDC;" align="left" + | | style="background:#DCDCDC;" align="left" + |<small>'''Adapted from [https://doi.org/10.2337/dc18-S002 American Diabetes Association (ADA)]'''</small> | ||
|} | |} | ||
Line 44: | Line 43: | ||
| style="background:#F5F5F5;" align="center" + |[[Fasting plasma glucose|FPG]] ≥126 mg/dL (7.0 mmol/L). [[Blood sugar|Fasting]] is defined as no caloric intake for at least 8 h.* | | style="background:#F5F5F5;" align="center" + |[[Fasting plasma glucose|FPG]] ≥126 mg/dL (7.0 mmol/L). [[Blood sugar|Fasting]] is defined as no caloric intake for at least 8 h.* | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |OR | | style="background:#F5F5F5;" align="center" + |OR | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |2-h PG ≥200 mg/dL (11.1 mmol/L) during an [[Glucose tolerance test|OGTT]]. The test should be performed as described by the WHO, using a [[glucose]] load containing the equivalent of 75 g anhydrous glucose dissolved in water.* | | style="background:#F5F5F5;" align="center" + |2-h PG ≥200 mg/dL (11.1 mmol/L) during an [[Glucose tolerance test|OGTT]]. The test should be performed as described by the WHO, using a [[glucose]] load containing the equivalent of 75 g anhydrous glucose dissolved in water.* | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |OR | | style="background:#F5F5F5;" align="center" + |OR | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |A1C ≥6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the [[Diabetes Control And Complications Trial|DCCT]] assay.* | | style="background:#F5F5F5;" align="center" + |A1C ≥6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the [[Diabetes Control And Complications Trial|DCCT]] assay.* | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |OR | | style="background:#F5F5F5;" align="center" + |OR | ||
|- | |- | ||
|style="background:#F5F5F5;" align="center" + |In a patient with classic symptoms of [[hyperglycemia]] or [[hyperglycemic crisis]], a random plasma glucose ≥200 mg/dL (11.1 mmol/L). | | style="background:#F5F5F5;" align="center" + |In a patient with classic symptoms of [[hyperglycemia]] or [[hyperglycemic crisis]], a random plasma glucose ≥200 mg/dL (11.1 mmol/L). | ||
|- | |- | ||
|style="background:#DCDCDC;" align="left" + |<small>'''Adapted from [https://doi.org/10.2337/dc18-S002 American Diabetes Association (ADA)]'''</small> | | style="background:#DCDCDC;" align="left" + |<small>'''Adapted from [https://doi.org/10.2337/dc18-S002 American Diabetes Association (ADA)]'''</small> | ||
|} | |} | ||
* In the absence of unequivocal [[hyperglycemia]], results should be confirmed by repeat testing.*In the absence of unequivocal [[hyperglycemia]], results should be confirmed by repeat testing. | * In the absence of unequivocal [[hyperglycemia]], results should be confirmed by repeat testing.*In the absence of unequivocal [[hyperglycemia]], results should be confirmed by repeat testing. |
Revision as of 18:34, 18 January 2019
Diabetes mellitus type 2 Microchapters |
Differentiating Diabetes Mellitus Type 2 from other Diseases |
Diagnosis |
Treatment |
Medical therapy |
Diabetes mellitus Main page |
Patient Information |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Trusha Tank, M.D.[2]
Overview
Fasting plasma glucose, 2-h plasma glucose during 75-g oral glucose tolerance test, and A1C are equally appropriate in diagnosing diabetes mellitus type 2.
Diagnostic recommendation
According to the ADA criteria, fasting plasma glucose, 2-h plasma glucose during 75-g oral glucose tolerance test, and A1C are equally appropriate in diagnosing diabetes mellitus type 2.[1]
ADA Recommendation For Diagnosis of Diabetes Mellitus Type 2 |
---|
|
|
|
|
|
|
Adapted from American Diabetes Association (ADA) |
Diagnostic criteria
ADA criteria for the diagnosis of type 2 DM follows:[2][3][4]
American Diabetes Association (ADA) Criteria for the Diagnosis of Diabetes |
---|
FPG ≥126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h.* |
OR |
2-h PG ≥200 mg/dL (11.1 mmol/L) during an OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.* |
OR |
A1C ≥6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay.* |
OR |
In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dL (11.1 mmol/L). |
Adapted from American Diabetes Association (ADA) |
- In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing.*In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing.
References
- ↑ "2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2018". Diabetes Care. 41 (Supplement 1): S13–S27. 2017. doi:10.2337/dc18-S002. ISSN 0149-5992.
- ↑ Nguyen Q, Nguyen L, Felicetta J (October 2008). "Evaluation and management of diabetes mellitus". Am Health Drug Benefits. 1 (8): 39–48. PMC 4106505. PMID 25126259.
- ↑ "Standards of medical care in diabetes--2008". Diabetes Care. 31 Suppl 1: S12–54. January 2008. doi:10.2337/dc08-S012. PMID 18165335.
- ↑ Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM (June 2011). "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus". Diabetes Care. 34 (6): e61–99. doi:10.2337/dc11-9998. PMC 3114322. PMID 21617108.